Peter Pan Du
Impact in
- Immunology top 10%
- interferon and immune responses
- Immune Cell Function and Interaction
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Immune Cell Function and Interaction 3
- interferon and immune responses 2
- Oncology 5
- CAR-T cell therapy research 2
- Cancer Immunotherapy and Biomarkers 2
- Peptidase Inhibition and Analysis 1
- Co-authors
- Matthew G. Durrant (1 shared paper)Josh Tycko (1 shared paper)Michaela M. Hinks (1 shared paper)Julia M. Schaepe (1 shared paper)Nicholas Thomas Perry (1 shared paper)Michael Cory Bassik (1 shared paper)Ami Siddharth Bhatt (1 shared paper)Patrick D. Hsu (1 shared paper)
- Journals
- Nature (5 papers)Immunity (2 papers)Nature Biotechnology (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)Nature Immunology (1 paper)
- Partner nations
- United StatesIsraelSwitzerland
In The Last Decade
Peter Pan Du
12 papers receiving 1.6k citations
Peter Pan Du's Hit Papers
Peers
Comparison fields: 5 of 81
- Immunology 477
- Oncology 373
- Molecular Biology 885
- Cancer Research 141
- Genetics 75
Countries citing papers authored by Peter Pan Du
This map shows the geographic impact of Peter Pan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Pan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Pan Du more than expected).
Fields of papers citing papers by Peter Pan Du
This network shows the impact of papers produced by Peter Pan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Pan Du. The network helps show where Peter Pan Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Pan Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade Hit paper breakdown → | 2018 | 529 |
| 2 | Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity Hit paper breakdown → | 2021 | 271 |
| 3 | Glioma synapses recruit mechanisms of adaptive plasticity Hit paper breakdown → | 2023 | 180 |
| 4 | 2022 | 149 | |
| 5 | 2022 | 139 | |
| 6 | 2023 | 119 | |
| 7 | 2021 | 65 | |
| 8 | 2024 | 46 | |
| 9 | 2022 | 36 | |
| 10 | 2024 | 23 | |
| 11 | 2024 | 13 | |
| 12 | 2024 | 7 | |
| 13 | 2026 | 0 |
About Peter Pan Du
Peter Pan Du is a scholar working on Immunology, Oncology, Molecular Biology, Developmental Neuroscience and Physiology, having authored 13 papers that have together received 1.6k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (4 papers), Immune Cell Function and Interaction (3 papers), RNA and protein synthesis mechanisms (2 papers), interferon and immune responses (2 papers), CAR-T cell therapy research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), RNA modifications and cancer (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Immunology (477 citations), Oncology (373 citations), Molecular Biology (885 citations), Cancer Research (141 citations) and Genetics (75 citations). Peter Pan Du has collaborated with scholars based in United States, Israel and Switzerland. Frequent co-authors include Matthew G. Durrant, Josh Tycko, Michaela M. Hinks, Julia M. Schaepe, Nicholas Thomas Perry, Michael Cory Bassik, Ami Siddharth Bhatt, Patrick D. Hsu, Alison Fanton and Lacramioara Bintu. Their work appears in journals such as Nature, Immunity, Nature Biotechnology, Journal for ImmunoTherapy of Cancer and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.